Orient Bio Inc
KRX:002630
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (35.1), the stock would be worth ₩-2 546.26 (551% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -7.8 | ₩565 |
0%
|
| Industry Average | 35.1 | ₩-2 546.26 |
-551%
|
| Country Average | 12.5 | ₩-909.07 |
-261%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
|
Orient Bio Inc
KRX:002630
|
67B KRW | -7.8 | -8.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 2 361.7 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
193.4B USD | 24.4 | 26 | |
| US |
|
Danaher Corp
NYSE:DHR
|
130.1B USD | 26.1 | 35 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 39.4 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.9B CHF | 26.2 | -122.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
296.1B CNY | 16.2 | 15.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 21.8 | 25 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.8B USD | 38.6 | 47.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.7B USD | 17 | 20 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 24.1 | 29.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.8 |
| Median | 12.5 |
| 70th Percentile | 23.2 |
| Max | 13 874.5 |
Other Multiples
Orient Bio Inc
Glance View
ORIENTBIO, Inc. engages in the research and development of biotechnology. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 104 full-time employees. The firm produces and supplies laboratory animals, including mice, rats, guinea pigs, hamsters, specific pathogen free (SPF) rabbits, beagles and others. The company also provides contract research organization (CRO) services, including CRO safety assessment and CRO new drug development services; medical and library equipment, such as barrier systems, and support services such as rodent surgery services, laboratory diagnostics services, transgenic services, genetic testing services and other services. In addition, along with its subsidiaries, the Company provides feeds, reagents, disinfectants, automobile components, power supply equipment, and other machines.
